Description
The Total Galactose Screening Assay is used for neonatal detection of galactosemia by measuring total galactose concentration in dried blood samples. It is intended for newborn screening and professional lab use.
The enzymatic reaction of the NEONATAL Total-Galactose Screening Assay is carried out in two stages. In the first stage, two enzymes—alkaline phosphatase and galactose dehydrogenase—convert total galactose (Galactose-1-phosphate and free galactose) in the newborn sample into products, such as NADH. In the second stage, the presence of NADH is quantified using colorimetry with tetrazolium salt. The absorbance intensity measured is directly proportional to the total galactose concentration in the sample.
Format: 288 – 576 – 1920 determinations
Storage: At 2-8°C
Possible automation: Semi-automatisation
Turn around time: Less than 1.5 hour
The Total Galactose Screening Assay is used for neonatal detection of galactosemia by measuring total galactose concentration in dried blood samples. It is intended for newborn screening and professional lab use.
Reviews
There are no reviews yet.